Tag: Patient Safety

Massachusetts researchers advance a novel gene-based COVID-19 vaccine

Editor's Note Researchers at the Massachusetts Eye and Ear, Massachusetts General Hospital, and Mass General Brigham, announced May 5 their progress towards the testing and development of an experimental vaccine against SARS-CoV-2 called AAVCOVID. The vaccine is currently in preclinical development with a plan to begin clinical testing in humans…

Read More

By: Judy Mathias
May 7, 2020
Share

AI identifies COVID-19 in chest x-rays

Editor's Note A new study from researchers in Hong Kong finds that the MAIL2.0 nowcast artificial intelligence (AI) algorithm, which was developed with concepts used in economics and meteorology, yields a high level of accuracy for identifying COVID-19 in chest x-rays, the May 5 AuntMinny.com reports. The algorithm yielded 84.7%…

Read More

By: Judy Mathias
May 7, 2020
Share

Heating could be best way to reprocess N95 respirators

Editor's Note This study from Stanford University tests five methods for disinfecting N95 masks and finds that heating them preserves their filtration efficiency for 50 cycles of disinfection. In the study, instead of analyzing N95 masks, which were needed by healthcare workers, the researchers examined pieces of the fabric used…

Read More

By: Judy Mathias
May 7, 2020
Share

FDA issues guidance to prevent device shortages during COVID-19 pandemic

Editor's Note The Food & Drug Administration (FDA) on May 6 issued a guidance to implement section 3121 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) as it relates to shortages and potential shortages of medical devices occurring during the COVID-19 pandemic. Manufacturers are required to notify…

Read More

By: Judy Mathias
May 7, 2020
Share

Use of AI to expedite search for COVID-19 treatments, vaccines

Editor's Note Researchers at Northwestern University in Chicago are using artificial intelligence (AI) to expedite the search for COVID-19 treatments and vaccines by shortening the expert review period. The AI tool prioritizes research that has the most potential to produce real solutions and ignores research that is unlikely to yield…

Read More

By: Judy Mathias
May 5, 2020
Share

Structure of coronavirus clue to high infection rate

Editor's Note Cornell University researchers studying the structure of the SARS-CoV-2 virus have found a unique feature that could explain why it is so transmissible between humans. The researchers identified a structural loop in the SARS-CoV-2 spike protein (ie, the area of the virus that facilitates entry into a cell)…

Read More

By: Judy Mathias
May 5, 2020
Share

CDC launches viral genomics consortium to map SARS-Cov-2 transmission

Editor's Note The Centers for Disease Control and Prevention (CDC) on May 1 announced the launch of the “SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)” consortium. This network of laboratories will speed the release of SARS-CoV-2 sequence data into the public domain for use by public…

Read More

By: Judy Mathias
May 5, 2020
Share

Happy National Nurses Month, Week, Day

Editor's Note This year, the American Nurses Association has extended the traditional National Nurses Week to a month of recognition, May 1-31. National Nurses Day, May 6, marks the beginning of National Nurses Week, which ends on May 12, the 200th anniversary of Florence Nightingale’s birthday. This year’s theme is “Nurses…

Read More

By: Judy Mathias
May 4, 2020
Share

CDC: Key COVID-19 updates for week 17

Editor's Note The Centers for Disease Control and Prevention on May 1 updated its weekly surveillance summary of COVID-19 activity in the US ending April 25. Among the updates: The percentage of specimens testing positive for SARS-CoV-2 decreased at public health and commercial laboratories and remained similar at clinical labs.…

Read More

By: Judy Mathias
May 4, 2020
Share

COVID-19: Randomized, double-blind, placebo-controlled, multicenter trial of remdesivir

Editor's Note In this randomized, double-blind, placebo-controlled, multicenter trial of remdesivir for the treatment of COVID-19, remdesivir was not associated with statistically significant clinical benefits. For the analysis, 237 patients were randomly assigned to either a treatment group with remdesivir (158 patients) or placebo (79 patients). Remdesivir use was not…

Read More

By: Judy Mathias
April 30, 2020
Share
Live chat by BoldChat